Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03293979

Enrollment

301

Registered

2017-09-26

Start date

2016-01-22

Completion date

2018-06-30

Last updated

2018-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flu

Brief summary

It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .

Interventions

DIAGNOSTIC_TESTTest A i Flu A&B implemented in emergency service

Test A i Flu A&B implemented in emergency service

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* respiratory symptoms * fever \>38°C * general symptoms of flu like pathology

Exclusion criteria

* cognitive disorders * patient with guardianship * patient already having a flu diagnosis in the last 7 days * without social protection.

Design outcomes

Primary

Measure	Time frame
time to have the result of the biological test	3 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026